Dallas Transplant Institute - , 00918

Dallas Transplant Institute entered the industry of Noncommercial Research Organizations in 0 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 541720, which describes it as a Noncommercial Research Organizations. For further clarification, the SIC classifies this business under the code 8733 and described it as a Noncommercial Research Organizations. The business provides service to the B2B market.

To acquire more information, please contact Diana Soto by calling No number given during business hours. You can also write to the business’ Single Location at 525 Avenue Fd Roosevelt # 711, , 00918. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Dallas Transplant Institute
Representative: Diana Soto
Place of Business: 525 Avenue Fd Roosevelt # 711, , 00918
Contact Number: No number given
Type of Service: Noncommercial Research Organizations
SIC Number: 8733
NAICS Number: 541720
Locality: Single Location
Market Type: B2B (Business to Business)
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

Dallas Transplant Institute is a company operating from , providing professional Noncommercial Research Organizations and relevant B2B variables. It was founded in 0 and registered with the SIC code 8733 as Noncommercial Research Organizations, and with the NAICS code 541720 as Noncommercial Research Organizations.

With a current employee count of 1 to 4, Dallas Transplant Institute has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Diana Soto at No number given for related queries, or to locate its Single Location using the coordinates .

The Single Location can also be found at the street address 525 Avenue Fd Roosevelt # 711 in , 00918 and can be engaged online through the company website at , the company Twitter , and Facebook page .